SlideShare a Scribd company logo
MEDIA USED FOR AST
TESTING
Tuba Bashir
•Disk diffusion method
•Agar dilution method
•Broth microdilution
Methods of Performing AST
Media Used for DST testing
CLSI
Mueller-Hinton agar (MHA)
Mueller-Hinton agar (MHA) with 5% sheep blood
Haemophilus Test Medium (HTM)
EUCAST
Mueller-Hinton agar (MHA)
Mueller-Hinton + 5% mechanically defibrinated horse blood + 20 mg/L
β-NAD
BSAC 2015
Iso-Sensitest agar
Iso-Sensitest agar supplemented with 5% defibrinated horse blood
(ISA + %5 horse blood + 20mg/L NAD may also be used)
Requirements of Isolated Organisms
Organism Medium Inoculum Incubation
time
Incubation
Condition
Reference
Enterobacteriaceae Mueller-Hinton
agar (MHA)
Growth Method or Direct
colony suspension,
equivalent to a 0.5
McFarland standard
16 -18 hours 35 °C ± 2;
ambient air
CLSI 2016
Pseudomonas aeruginosa Mueller-Hinton
agar (MHA)
Growth Method or Direct
colony suspension,
equivalent to a 0.5
McFarland standard
16 -18 hours 35 °C ± 2;
ambient air
CLSI 2016
Stenotrophomonas
maltophilia
Mueller-Hinton
agar (MHA)
Growth Method or Direct
colony suspension,
equivalent to a 0.5
McFarland standard
20-24
hours
35 °C ± 2;
ambient air
CLSI 2016
Acinetobacter spp. Mueller-Hinton
agar (MHA)
Growth Method or Direct
colony suspension,
equivalent to a 0.5
McFarland standard
20-24
hours
35 °C ± 2;
ambient air
CLSI 2016
Burkholderia cepacia
complex
Mueller-Hinton
agar (MHA)
Growth Method or Direct
colony suspension,
equivalent to a 0.5
McFarland standard
20-24
hours
35 °C ± 2;
ambient air
CLSI 2016
Staphylococcus spp. Mueller-Hinton
agar (MHA)
Direct colony suspension,
equivalent to a 0.5
McFarland standard
16 -18 hours;
24 hours CoNS
and Cefoxitin
35 °C ± 2;
ambient air
CLSI 2016
Enterococcus spp. Mueller-Hinton
agar (MHA)
Growth Method or Direct
colony suspension,
equivalent to a 0.5
McFarland standard
20-24hours 35 °C ± 2;
ambient air
CLSI 2016
Streptococcus spp. β –
Hemolytic Group
Mueller-Hinton
agar (MHA) with
5% sheep blood
Direct colony suspension,
equivalent to a 0.5
McFarland standard
20-24
hours
35 °C ± 2;
5% CO²
CLSI 2016
Streptococcus pneumoniae Mueller-Hinton
agar (MHA) with
5% sheep blood
Direct colony suspension
(18-20 hr. blood agar plate),
equivalent to a 0.5
McFarland standard
24hours 35 °C ± 2;
5% CO²
CLSI 2016
Streptococcus spp.
Viridans Group
Mueller-Hinton
agar (MHA) with
5% sheep blood
Direct colony suspension
(18-20 hr. blood agar plate),
equivalent to a 0.5
McFarland standard
24hours 35 °C ± 2;
5% CO²
CLSI 2016
Neisseria meningitidis Mueller-Hinton
agar (MHA) with
5% sheep blood
Direct colony suspension
(18-20 hr. Chocolate agar
plate preferably, blood agar
may be used),equivalent to
a 0.5 McFarland standard
24hours 35 °C ± 2;
5% CO²
CLSI 2016
Haemophilus influenzae
and Haemophilus
parainfluenzae
Haemophilus
Test Medium
(HTM)
Direct colony suspension,
equivalent to a 0.5
McFarland standard
16 -18 hours 35 °C ± 2;
5% CO²
CLSI 2016
The suspension should optimally be used within 15 min and always within 60 min of preparation.
Note: Chocolate Agar is used in replace of Haemophilus Test Medium (HTM)
Human Blood (expired blood bag-from blood bank) in replace of sheep blood
Mueller-Hinton agar
it is a non-selective, non-differential
medium
it contains starch. Starch is known to absorb
toxins released from bacteria, so that they
cannot interfere with the antibiotics
it is a loose agar. This allows for better
diffusion of the antibiotics than most other
plates. A better diffusion leads to a true
zone of inhibition.
Media Preparation
Materials
•Mueller Hinton dehydrated powder
•Weighing balance, weighing boats, spatula, flasks,
thermometer, sterile petri dishes, autoclave, autoclave tape,
pH meter, water bath
•Distilled water
Procedure
Weigh Mueller Hinton agar according to the instructions given on the label of the
media powder. Suspend the powder in distilled water. completely dissolve the
powder.
Autoclave at 121oC for 15-20 minutes.
Immediately after autoclaving, allow the agar to cool to 50oC waterbath.
Pour the freshly prepared and cooled medium into sterile petri dishes on a level
horizontal surface to give a uniform depth of approximately 4 mm.
This corresponds to 60 ml to 70 ml of medium for plates with a diameter of 150
mm
25 - 30 ml for plates with a diameter of 100 mm
& 20 ml for 90mm plate.
Allow the agar plates to cool further to room temperature.
Note: Media Bottles labelled with media prepare (MHA), on autoclave tape.
Media dispensing is best done inside the BSC to minimize contamination.
TO PREPARE MUELLER HINTON AGAR WITH SHEEP BLOOD (MHB): Cool
medium to 50oC and aseptically add 5% sterile defibrinated sheep blood.
Mix well.
•Check the pH of each batch of MHA and MHB when the medium is
prepared. The agar medium should have a pH of 7.3 ± 0.1 at room
temperature.
•If the pH is outside the range, the batch of the Mueller Hinton plates
should be discarded and a new batch of plates prepared.
•If the pH for every batch is too high or low, the entire lot of
dehydrated medium may have to be returned to the manufacturer as
unsatisfactory.
•Allow the medium to cool further to room temperature to remove
excess moisture.
Do not leave lids ajar because this medium is easily
contaminated.
a.Label plates with media name and preparation date.
b.Wrap plates in plastic bags, 10 plates per bag. Leave appropriate
number of plates outside for quality control (QC).
c.Label media bags with media name, preparation date, expiry date,
and storage temperature.
d.Record media preparation on appropriate form.
e.Perform media QC.
Storage
Store wrapped plates at 2o to 8oC for up to 8 weeks.
Prior to inoculation with patient specimens, prepared media that have been
refrigerated should be removed from refrigeration and equilibrated to room
temperature. This is to allow water of condensation to evaporate or dissipate and to
avoid temperature shock to the inoculum.
Just before use, if excess moisture is on the surface, MHA plates can be placed in
the incubator (35o to 37oC) until the moisture evaporates (usually 10–30 minutes).
•Quality Control
For MHA, the media preparation record is merged with the media QC form.
•Incubate at least one un inoculated agar plate from each batch or lot
overnight or longer to verify sterility of the medium.
•Test each new batch or lot of agar plates or disks with the appropriate QC
strains (see antimicrobial susceptibility testing AST QC forms) to determine if
zone sizes obtained with the batch or lot fall within the expected range (see
M100 table).
•Do not use media with unacceptable QC results. Document QC failures and
corrective action taken. Inform tech-in-charge of all QC failures.
Inoculation Procedure
Refer to SOP for Antimicrobial Susceptibility Testing AST
Interpretation of Results:
Refer to SOP for Antimicrobial Susceptibility Testing
Procedural Notes
•When dissolving media base, add the exact weight to approximately one
half of the volume of purified water. After thorough mixing, add the
remainder of the water with care being taken to wash down the sides of the
container.
•Dissolution of the media base is enhanced by allowing agar preparations to
stand for 5 minutes with occasional agitation Agar plates stored in
refrigerator for several days should be wrapped in plastic bags prior to
refrigeration to prevent moisture loss.
•Mueller Hinton agar deeper than 4 mm may cause false resistant results,
and agar less than 4 mm deep may be associated with a false susceptibility
report.
•A pH outside the range of 7.3 ± 0.1 at 25oC may adversely affect
susceptibility test results. If the pH is less than 7.2, certain drugs will
appear to lose potency (aminoglycoside and macrolides); while other agents
may appear to have excessive activity (e.g., tetracyclines). If the pH is greater
that 7.4, the opposite effects can be expected.
Preparation
date
Media Powder AST QC
Result
(Passed/Faile
d)
Sterility test
(Growth/No
growth)
Quantit
y
prepare
d
pH
Prepared by:
Tech
Initial/date
Supervis
or
initial/dat
e
Manufactur
er
# Expiry date
MICROBIOLOGY LABORATORY
Media Preparation and Quality Control Record: Mueller Hinton Agar
Test for sterility: Incubate uninoculated media at 35oC for 48 hours. Acceptable result - No growth
QC Organisms and Expected Results: See weekly AST QC form
QC Procedure: See AST procedure
QC Frequency: Perform QC on each batch of prepared media.
If QC failed, do not use batch of media. Inform supervisor immediately. Document all QC failures and corrective action taken.
QC failure/Corrective Action:
_____________________________________________________________________________________________________
__________________________________________________________________________________________________________
4.2 Media QC Form: Mueller Hinton Agar
Automated Media Preparation
Mediclave 9
APS 320
Quality tests
chemical and biological parameter
checked to ensure end products
meet product quality specification,
packaging,labelling and storage are
important
Organism Strain Characteristics
Enterobacteriaceae Escherichia coli ATCC 25922
Pseudomonas aeruginosa 27853
Escherichia coli ATCC 35218
Susceptible, wild-type
(for Carbapenems)
(for β-lactam/ β –lactamase inhibitor
combinations)
Pseudomonas aeruginosa Pseudomonas aeruginosa 27853
Escherichia coli ATCC 35218
(for Carbapenems)
(for β-lactam/ β –lactamase inhibitor
combinations)
Acinetobacter specie Pseudomonas aeruginosa 27853
Escherichia coli ATCC 35218
Escherichia coli ATCC 25922
Susceptible, wild-type
(for β-lactam/ β –lactamase inhibitor
combinations)
(for tetracyclines and trimethoprim-
sulfamethoxazole)
Burkholderia cepacia complex Pseudomonas aeruginosa 27853
Escherichia coli ATCC 35218
Escherichia coli ATCC 25922
Susceptible, wild-type
(for β-lactam/ β –lactamase inhibitor
combinations)
(for Chloramphenicol, minocycline, and
trimethoprim-sulfamethoxazole)
Stenotrophomonas maltophilia Pseudomonas aeruginosa 27853
Escherichia coli ATCC 35218
Escherichia coli ATCC 25922
Susceptible, wild-type
(for β-lactam/ β –lactamase inhibitor
combinations)
(for Chloramphenicol, minocycline, and
trimethoprim-sulfamethoxazole)
Staphylococcus aureus Staph. aureus ATCC 25923
Enterococcus spp. Staph. aureus ATCC 25923
Streptococcus pneumoniae Strept. pneumoniae ATCC 49619
Streptococcus spp. β-hemolytic group Strept. pneumoniae ATCC 49619
Streptococcus spp. Viridans hemolytic
group
Strept. pneumoniae ATCC 49619
Neisseria meningitidis Strept. pneumoniae ATCC 49619
See Table 4A & 4B of CLSI (M100-S26) or QC file for QC ranges
Use specified control strains to monitor the performance of the test.
Culture Media used for Antimicrobial Testing
Culture Media used for Antimicrobial Testing
Culture Media used for Antimicrobial Testing
Culture Media used for Antimicrobial Testing

More Related Content

What's hot

Sterile testing
Sterile testingSterile testing
Total aflatoxin
Total aflatoxinTotal aflatoxin
Total aflatoxin
mzk57
 
BET testing USP85 an Introduction
BET testing USP85 an Introduction BET testing USP85 an Introduction
BET testing USP85 an Introduction
Amrutha Raiker
 
Sterility testing
Sterility testingSterility testing
Sterility testing
shital trivedi
 
Pyrogen test parth
Pyrogen test parthPyrogen test parth
Pyrogen test parth
Parth Khandheria
 
2.6.12. microbiological examination of non sterile products (total viable aer...
2.6.12. microbiological examination of non sterile products (total viable aer...2.6.12. microbiological examination of non sterile products (total viable aer...
2.6.12. microbiological examination of non sterile products (total viable aer...
Guide_Consulting
 
Endotoxin testing
Endotoxin testing Endotoxin testing
Endotoxin testing
Gibraltar Laboratories
 
2019 Feed and Grain Mycotoxin Workshop Presentation
2019 Feed and Grain Mycotoxin Workshop Presentation2019 Feed and Grain Mycotoxin Workshop Presentation
2019 Feed and Grain Mycotoxin Workshop Presentation
Patrick Frasco
 
Bacterial Endotoxin Test
Bacterial Endotoxin TestBacterial Endotoxin Test
Bacterial Endotoxin Test
Pharmaguideline
 
Aflatoxin m1
Aflatoxin m1Aflatoxin m1
Aflatoxin m1
mzk57
 
cUSP 2021-2022 Microbial Enumeration Tests for Nutritional and Dietary Supple...
cUSP 2021-2022 Microbial Enumeration Tests for Nutritional and Dietary Supple...cUSP 2021-2022 Microbial Enumeration Tests for Nutritional and Dietary Supple...
cUSP 2021-2022 Microbial Enumeration Tests for Nutritional and Dietary Supple...
Gibraltar Laboratories
 
Microbiological limit test amit $hah
Microbiological  limit test  amit $hahMicrobiological  limit test  amit $hah
Microbiological limit test amit $hahAmit Shah
 
Microbiological limit test amit $hah
Microbiological  limit test amit $hahMicrobiological  limit test amit $hah
Microbiological limit test amit $hahAmit Shah
 
Microbial Limit Test- An Over view
Microbial Limit Test- An Over view Microbial Limit Test- An Over view
Microbial Limit Test- An Over view
Srinath Sasidharan
 
Microbial limit tests I.P By Dr.P.Srinivas Jangaon institute of pharmaceutica...
Microbial limit tests I.P By Dr.P.Srinivas Jangaon institute of pharmaceutica...Microbial limit tests I.P By Dr.P.Srinivas Jangaon institute of pharmaceutica...
Microbial limit tests I.P By Dr.P.Srinivas Jangaon institute of pharmaceutica...
cnupogu
 

What's hot (15)

Sterile testing
Sterile testingSterile testing
Sterile testing
 
Total aflatoxin
Total aflatoxinTotal aflatoxin
Total aflatoxin
 
BET testing USP85 an Introduction
BET testing USP85 an Introduction BET testing USP85 an Introduction
BET testing USP85 an Introduction
 
Sterility testing
Sterility testingSterility testing
Sterility testing
 
Pyrogen test parth
Pyrogen test parthPyrogen test parth
Pyrogen test parth
 
2.6.12. microbiological examination of non sterile products (total viable aer...
2.6.12. microbiological examination of non sterile products (total viable aer...2.6.12. microbiological examination of non sterile products (total viable aer...
2.6.12. microbiological examination of non sterile products (total viable aer...
 
Endotoxin testing
Endotoxin testing Endotoxin testing
Endotoxin testing
 
2019 Feed and Grain Mycotoxin Workshop Presentation
2019 Feed and Grain Mycotoxin Workshop Presentation2019 Feed and Grain Mycotoxin Workshop Presentation
2019 Feed and Grain Mycotoxin Workshop Presentation
 
Bacterial Endotoxin Test
Bacterial Endotoxin TestBacterial Endotoxin Test
Bacterial Endotoxin Test
 
Aflatoxin m1
Aflatoxin m1Aflatoxin m1
Aflatoxin m1
 
cUSP 2021-2022 Microbial Enumeration Tests for Nutritional and Dietary Supple...
cUSP 2021-2022 Microbial Enumeration Tests for Nutritional and Dietary Supple...cUSP 2021-2022 Microbial Enumeration Tests for Nutritional and Dietary Supple...
cUSP 2021-2022 Microbial Enumeration Tests for Nutritional and Dietary Supple...
 
Microbiological limit test amit $hah
Microbiological  limit test  amit $hahMicrobiological  limit test  amit $hah
Microbiological limit test amit $hah
 
Microbiological limit test amit $hah
Microbiological  limit test amit $hahMicrobiological  limit test amit $hah
Microbiological limit test amit $hah
 
Microbial Limit Test- An Over view
Microbial Limit Test- An Over view Microbial Limit Test- An Over view
Microbial Limit Test- An Over view
 
Microbial limit tests I.P By Dr.P.Srinivas Jangaon institute of pharmaceutica...
Microbial limit tests I.P By Dr.P.Srinivas Jangaon institute of pharmaceutica...Microbial limit tests I.P By Dr.P.Srinivas Jangaon institute of pharmaceutica...
Microbial limit tests I.P By Dr.P.Srinivas Jangaon institute of pharmaceutica...
 

Similar to Culture Media used for Antimicrobial Testing

Usp 40 -71 sterility tests
Usp 40 -71 sterility testsUsp 40 -71 sterility tests
Usp 40 -71 sterility tests
Bhargava Gottam
 
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
Ms. Pooja Bhandare
 
part6-230110081003-34eff4a5 (1).pdf
part6-230110081003-34eff4a5 (1).pdfpart6-230110081003-34eff4a5 (1).pdf
part6-230110081003-34eff4a5 (1).pdf
imshrikant
 
3. Antimicrobial Effectiveness Final.pptx
3. Antimicrobial Effectiveness Final.pptx3. Antimicrobial Effectiveness Final.pptx
3. Antimicrobial Effectiveness Final.pptx
Rushikesh Tamhane
 
iso6888-1Staph aureus [Autosaved] (1).pptx
iso6888-1Staph aureus [Autosaved] (1).pptxiso6888-1Staph aureus [Autosaved] (1).pptx
iso6888-1Staph aureus [Autosaved] (1).pptx
BassantAFathallah
 
Broth microdilution reference methodology
Broth microdilution reference methodologyBroth microdilution reference methodology
Broth microdilution reference methodology
ILRI
 
USP STERILITY TESTING BY ROSHAN GOMAJI BODHE
USP STERILITY TESTING BY ROSHAN GOMAJI BODHEUSP STERILITY TESTING BY ROSHAN GOMAJI BODHE
USP STERILITY TESTING BY ROSHAN GOMAJI BODHE
Roshan Bodhe
 
Ochratoxin
OchratoxinOchratoxin
Ochratoxin
mzk57
 
Antibiotic sensitivity testing
Antibiotic sensitivity testing  Antibiotic sensitivity testing
Antibiotic sensitivity testing
Aneesha K N
 
Preparation of large volume and small volume parenteral
Preparation of large volume and small volume parenteralPreparation of large volume and small volume parenteral
Preparation of large volume and small volume parenteral
sangram maskar
 
Aseptic Process Technology.pptx
Aseptic Process Technology.pptxAseptic Process Technology.pptx
Aseptic Process Technology.pptx
AbhishekJadhav189260
 
Microbial limit tests I.P by Dr.P.srinivas
Microbial limit tests I.P by Dr.P.srinivas Microbial limit tests I.P by Dr.P.srinivas
Microbial limit tests I.P by Dr.P.srinivas
cnupogu
 
Sterility testing USP 71
Sterility testing USP 71Sterility testing USP 71
Sterility testing USP 71
Gibraltar Laboratories
 

Similar to Culture Media used for Antimicrobial Testing (13)

Usp 40 -71 sterility tests
Usp 40 -71 sterility testsUsp 40 -71 sterility tests
Usp 40 -71 sterility tests
 
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
 
part6-230110081003-34eff4a5 (1).pdf
part6-230110081003-34eff4a5 (1).pdfpart6-230110081003-34eff4a5 (1).pdf
part6-230110081003-34eff4a5 (1).pdf
 
3. Antimicrobial Effectiveness Final.pptx
3. Antimicrobial Effectiveness Final.pptx3. Antimicrobial Effectiveness Final.pptx
3. Antimicrobial Effectiveness Final.pptx
 
iso6888-1Staph aureus [Autosaved] (1).pptx
iso6888-1Staph aureus [Autosaved] (1).pptxiso6888-1Staph aureus [Autosaved] (1).pptx
iso6888-1Staph aureus [Autosaved] (1).pptx
 
Broth microdilution reference methodology
Broth microdilution reference methodologyBroth microdilution reference methodology
Broth microdilution reference methodology
 
USP STERILITY TESTING BY ROSHAN GOMAJI BODHE
USP STERILITY TESTING BY ROSHAN GOMAJI BODHEUSP STERILITY TESTING BY ROSHAN GOMAJI BODHE
USP STERILITY TESTING BY ROSHAN GOMAJI BODHE
 
Ochratoxin
OchratoxinOchratoxin
Ochratoxin
 
Antibiotic sensitivity testing
Antibiotic sensitivity testing  Antibiotic sensitivity testing
Antibiotic sensitivity testing
 
Preparation of large volume and small volume parenteral
Preparation of large volume and small volume parenteralPreparation of large volume and small volume parenteral
Preparation of large volume and small volume parenteral
 
Aseptic Process Technology.pptx
Aseptic Process Technology.pptxAseptic Process Technology.pptx
Aseptic Process Technology.pptx
 
Microbial limit tests I.P by Dr.P.srinivas
Microbial limit tests I.P by Dr.P.srinivas Microbial limit tests I.P by Dr.P.srinivas
Microbial limit tests I.P by Dr.P.srinivas
 
Sterility testing USP 71
Sterility testing USP 71Sterility testing USP 71
Sterility testing USP 71
 

Recently uploaded

Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Health Catalyst
 
Suraj Goswami Journey From Guru Kashi University
Suraj Goswami Journey From Guru Kashi UniversitySuraj Goswami Journey From Guru Kashi University
Suraj Goswami Journey From Guru Kashi University
Suraj Goswami
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
Rommel Luis III Israel
 
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsxChild Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Sankalpa Gunathilaka
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPYRECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
Isha Jaiswal
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Guillermo Rivera
 
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic IllnessesPrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx Program
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
NEHA GUPTA
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
ILC- UK
 
Ginseng for Stamina Boost Your Energy and Endurance Naturally.pptx
Ginseng for Stamina Boost Your Energy and Endurance Naturally.pptxGinseng for Stamina Boost Your Energy and Endurance Naturally.pptx
Ginseng for Stamina Boost Your Energy and Endurance Naturally.pptx
SkyTagBioteq
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
ssuser787e5c1
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
nktiacc3
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
The Lifesciences Magazine
 
KEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docxKEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docx
NX Healthcare
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
eurohealthleaders
 
ALKAMAGIC PLAN 1350.pdf plan based of door to door delivery of alkaline water...
ALKAMAGIC PLAN 1350.pdf plan based of door to door delivery of alkaline water...ALKAMAGIC PLAN 1350.pdf plan based of door to door delivery of alkaline water...
ALKAMAGIC PLAN 1350.pdf plan based of door to door delivery of alkaline water...
rowala30
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
Dr Rachana Gujar
 
Cardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing studentCardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing student
fahmyahmed789
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
CANSA The Cancer Association of South Africa
 

Recently uploaded (20)

Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
 
Suraj Goswami Journey From Guru Kashi University
Suraj Goswami Journey From Guru Kashi UniversitySuraj Goswami Journey From Guru Kashi University
Suraj Goswami Journey From Guru Kashi University
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
 
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsxChild Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPYRECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
 
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic IllnessesPrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic Illnesses
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
 
Ginseng for Stamina Boost Your Energy and Endurance Naturally.pptx
Ginseng for Stamina Boost Your Energy and Endurance Naturally.pptxGinseng for Stamina Boost Your Energy and Endurance Naturally.pptx
Ginseng for Stamina Boost Your Energy and Endurance Naturally.pptx
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
 
KEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docxKEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docx
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
 
ALKAMAGIC PLAN 1350.pdf plan based of door to door delivery of alkaline water...
ALKAMAGIC PLAN 1350.pdf plan based of door to door delivery of alkaline water...ALKAMAGIC PLAN 1350.pdf plan based of door to door delivery of alkaline water...
ALKAMAGIC PLAN 1350.pdf plan based of door to door delivery of alkaline water...
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
 
Cardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing studentCardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing student
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
 

Culture Media used for Antimicrobial Testing

  • 1. MEDIA USED FOR AST TESTING Tuba Bashir
  • 2. •Disk diffusion method •Agar dilution method •Broth microdilution Methods of Performing AST
  • 3. Media Used for DST testing CLSI Mueller-Hinton agar (MHA) Mueller-Hinton agar (MHA) with 5% sheep blood Haemophilus Test Medium (HTM) EUCAST Mueller-Hinton agar (MHA) Mueller-Hinton + 5% mechanically defibrinated horse blood + 20 mg/L β-NAD BSAC 2015 Iso-Sensitest agar Iso-Sensitest agar supplemented with 5% defibrinated horse blood (ISA + %5 horse blood + 20mg/L NAD may also be used)
  • 4. Requirements of Isolated Organisms Organism Medium Inoculum Incubation time Incubation Condition Reference Enterobacteriaceae Mueller-Hinton agar (MHA) Growth Method or Direct colony suspension, equivalent to a 0.5 McFarland standard 16 -18 hours 35 °C ± 2; ambient air CLSI 2016 Pseudomonas aeruginosa Mueller-Hinton agar (MHA) Growth Method or Direct colony suspension, equivalent to a 0.5 McFarland standard 16 -18 hours 35 °C ± 2; ambient air CLSI 2016 Stenotrophomonas maltophilia Mueller-Hinton agar (MHA) Growth Method or Direct colony suspension, equivalent to a 0.5 McFarland standard 20-24 hours 35 °C ± 2; ambient air CLSI 2016 Acinetobacter spp. Mueller-Hinton agar (MHA) Growth Method or Direct colony suspension, equivalent to a 0.5 McFarland standard 20-24 hours 35 °C ± 2; ambient air CLSI 2016 Burkholderia cepacia complex Mueller-Hinton agar (MHA) Growth Method or Direct colony suspension, equivalent to a 0.5 McFarland standard 20-24 hours 35 °C ± 2; ambient air CLSI 2016 Staphylococcus spp. Mueller-Hinton agar (MHA) Direct colony suspension, equivalent to a 0.5 McFarland standard 16 -18 hours; 24 hours CoNS and Cefoxitin 35 °C ± 2; ambient air CLSI 2016
  • 5. Enterococcus spp. Mueller-Hinton agar (MHA) Growth Method or Direct colony suspension, equivalent to a 0.5 McFarland standard 20-24hours 35 °C ± 2; ambient air CLSI 2016 Streptococcus spp. β – Hemolytic Group Mueller-Hinton agar (MHA) with 5% sheep blood Direct colony suspension, equivalent to a 0.5 McFarland standard 20-24 hours 35 °C ± 2; 5% CO² CLSI 2016 Streptococcus pneumoniae Mueller-Hinton agar (MHA) with 5% sheep blood Direct colony suspension (18-20 hr. blood agar plate), equivalent to a 0.5 McFarland standard 24hours 35 °C ± 2; 5% CO² CLSI 2016 Streptococcus spp. Viridans Group Mueller-Hinton agar (MHA) with 5% sheep blood Direct colony suspension (18-20 hr. blood agar plate), equivalent to a 0.5 McFarland standard 24hours 35 °C ± 2; 5% CO² CLSI 2016 Neisseria meningitidis Mueller-Hinton agar (MHA) with 5% sheep blood Direct colony suspension (18-20 hr. Chocolate agar plate preferably, blood agar may be used),equivalent to a 0.5 McFarland standard 24hours 35 °C ± 2; 5% CO² CLSI 2016 Haemophilus influenzae and Haemophilus parainfluenzae Haemophilus Test Medium (HTM) Direct colony suspension, equivalent to a 0.5 McFarland standard 16 -18 hours 35 °C ± 2; 5% CO² CLSI 2016 The suspension should optimally be used within 15 min and always within 60 min of preparation. Note: Chocolate Agar is used in replace of Haemophilus Test Medium (HTM) Human Blood (expired blood bag-from blood bank) in replace of sheep blood
  • 6. Mueller-Hinton agar it is a non-selective, non-differential medium it contains starch. Starch is known to absorb toxins released from bacteria, so that they cannot interfere with the antibiotics it is a loose agar. This allows for better diffusion of the antibiotics than most other plates. A better diffusion leads to a true zone of inhibition.
  • 7. Media Preparation Materials •Mueller Hinton dehydrated powder •Weighing balance, weighing boats, spatula, flasks, thermometer, sterile petri dishes, autoclave, autoclave tape, pH meter, water bath •Distilled water
  • 8. Procedure Weigh Mueller Hinton agar according to the instructions given on the label of the media powder. Suspend the powder in distilled water. completely dissolve the powder. Autoclave at 121oC for 15-20 minutes. Immediately after autoclaving, allow the agar to cool to 50oC waterbath. Pour the freshly prepared and cooled medium into sterile petri dishes on a level horizontal surface to give a uniform depth of approximately 4 mm. This corresponds to 60 ml to 70 ml of medium for plates with a diameter of 150 mm 25 - 30 ml for plates with a diameter of 100 mm & 20 ml for 90mm plate. Allow the agar plates to cool further to room temperature. Note: Media Bottles labelled with media prepare (MHA), on autoclave tape. Media dispensing is best done inside the BSC to minimize contamination.
  • 9. TO PREPARE MUELLER HINTON AGAR WITH SHEEP BLOOD (MHB): Cool medium to 50oC and aseptically add 5% sterile defibrinated sheep blood. Mix well. •Check the pH of each batch of MHA and MHB when the medium is prepared. The agar medium should have a pH of 7.3 ± 0.1 at room temperature. •If the pH is outside the range, the batch of the Mueller Hinton plates should be discarded and a new batch of plates prepared. •If the pH for every batch is too high or low, the entire lot of dehydrated medium may have to be returned to the manufacturer as unsatisfactory. •Allow the medium to cool further to room temperature to remove excess moisture. Do not leave lids ajar because this medium is easily contaminated. a.Label plates with media name and preparation date. b.Wrap plates in plastic bags, 10 plates per bag. Leave appropriate number of plates outside for quality control (QC). c.Label media bags with media name, preparation date, expiry date, and storage temperature. d.Record media preparation on appropriate form. e.Perform media QC.
  • 10. Storage Store wrapped plates at 2o to 8oC for up to 8 weeks. Prior to inoculation with patient specimens, prepared media that have been refrigerated should be removed from refrigeration and equilibrated to room temperature. This is to allow water of condensation to evaporate or dissipate and to avoid temperature shock to the inoculum. Just before use, if excess moisture is on the surface, MHA plates can be placed in the incubator (35o to 37oC) until the moisture evaporates (usually 10–30 minutes). •Quality Control For MHA, the media preparation record is merged with the media QC form. •Incubate at least one un inoculated agar plate from each batch or lot overnight or longer to verify sterility of the medium. •Test each new batch or lot of agar plates or disks with the appropriate QC strains (see antimicrobial susceptibility testing AST QC forms) to determine if zone sizes obtained with the batch or lot fall within the expected range (see M100 table). •Do not use media with unacceptable QC results. Document QC failures and corrective action taken. Inform tech-in-charge of all QC failures. Inoculation Procedure Refer to SOP for Antimicrobial Susceptibility Testing AST Interpretation of Results: Refer to SOP for Antimicrobial Susceptibility Testing
  • 11. Procedural Notes •When dissolving media base, add the exact weight to approximately one half of the volume of purified water. After thorough mixing, add the remainder of the water with care being taken to wash down the sides of the container. •Dissolution of the media base is enhanced by allowing agar preparations to stand for 5 minutes with occasional agitation Agar plates stored in refrigerator for several days should be wrapped in plastic bags prior to refrigeration to prevent moisture loss. •Mueller Hinton agar deeper than 4 mm may cause false resistant results, and agar less than 4 mm deep may be associated with a false susceptibility report. •A pH outside the range of 7.3 ± 0.1 at 25oC may adversely affect susceptibility test results. If the pH is less than 7.2, certain drugs will appear to lose potency (aminoglycoside and macrolides); while other agents may appear to have excessive activity (e.g., tetracyclines). If the pH is greater that 7.4, the opposite effects can be expected.
  • 12. Preparation date Media Powder AST QC Result (Passed/Faile d) Sterility test (Growth/No growth) Quantit y prepare d pH Prepared by: Tech Initial/date Supervis or initial/dat e Manufactur er # Expiry date MICROBIOLOGY LABORATORY Media Preparation and Quality Control Record: Mueller Hinton Agar Test for sterility: Incubate uninoculated media at 35oC for 48 hours. Acceptable result - No growth QC Organisms and Expected Results: See weekly AST QC form QC Procedure: See AST procedure QC Frequency: Perform QC on each batch of prepared media. If QC failed, do not use batch of media. Inform supervisor immediately. Document all QC failures and corrective action taken. QC failure/Corrective Action: _____________________________________________________________________________________________________ __________________________________________________________________________________________________________ 4.2 Media QC Form: Mueller Hinton Agar
  • 14. Quality tests chemical and biological parameter checked to ensure end products meet product quality specification, packaging,labelling and storage are important
  • 15. Organism Strain Characteristics Enterobacteriaceae Escherichia coli ATCC 25922 Pseudomonas aeruginosa 27853 Escherichia coli ATCC 35218 Susceptible, wild-type (for Carbapenems) (for β-lactam/ β –lactamase inhibitor combinations) Pseudomonas aeruginosa Pseudomonas aeruginosa 27853 Escherichia coli ATCC 35218 (for Carbapenems) (for β-lactam/ β –lactamase inhibitor combinations) Acinetobacter specie Pseudomonas aeruginosa 27853 Escherichia coli ATCC 35218 Escherichia coli ATCC 25922 Susceptible, wild-type (for β-lactam/ β –lactamase inhibitor combinations) (for tetracyclines and trimethoprim- sulfamethoxazole) Burkholderia cepacia complex Pseudomonas aeruginosa 27853 Escherichia coli ATCC 35218 Escherichia coli ATCC 25922 Susceptible, wild-type (for β-lactam/ β –lactamase inhibitor combinations) (for Chloramphenicol, minocycline, and trimethoprim-sulfamethoxazole) Stenotrophomonas maltophilia Pseudomonas aeruginosa 27853 Escherichia coli ATCC 35218 Escherichia coli ATCC 25922 Susceptible, wild-type (for β-lactam/ β –lactamase inhibitor combinations) (for Chloramphenicol, minocycline, and trimethoprim-sulfamethoxazole) Staphylococcus aureus Staph. aureus ATCC 25923 Enterococcus spp. Staph. aureus ATCC 25923 Streptococcus pneumoniae Strept. pneumoniae ATCC 49619 Streptococcus spp. β-hemolytic group Strept. pneumoniae ATCC 49619 Streptococcus spp. Viridans hemolytic group Strept. pneumoniae ATCC 49619 Neisseria meningitidis Strept. pneumoniae ATCC 49619 See Table 4A & 4B of CLSI (M100-S26) or QC file for QC ranges Use specified control strains to monitor the performance of the test.